 |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Friday, March 19, 2010
|
|
|
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Friday, March 19, 2010
|
ATTENTION: The FDA announced on March 30, 2007, that the maker of the drug Zelnorm (generic name: tegaserod maleate) has agreed to stop marketing the drug due to health safety concerns.
If you are taking Zelnorm (tegaserod maleate), you should consult with your physician as soon as possible about stopping the medication and your treatment alternatives.
For more information, please follow the link below:
This article is a NetWellness exclusive. 
Last Reviewed: Apr 02, 2007
|
Peter J. Embi, MD, MS Assistant Professor Division of General Internal Medicine Department of Internal Medicine College of Medicine University of Cincinnati |
|
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|